Eradicating malaria is biologically feasible and a lofty aim, the World Health Organization (WHO) said on Friday, but the focus for now should be getting the funds, tools and political will to control it.
Malaria has killed more than 1,800 people in Burundi this year, the United Nations (UN)’s humanitarian agency says, a death toll rivaling a deadly Ebola outbreak in the neighboring Democratic Republic of the Congo.
Research on a radical new way to combat malaria and other devastating diseases could be knocked off track if a UN biodiversity conference imposes a moratorium on the work, a group of scientists have said.
Study findings showed that standard molecular diagnostics detect most potentially transmissible malaria infections and cannot be replaced by rapid diagnostic testing to screen for potential Plasmodium falciparum transmitters, researchers reported in The Lancet Infectious Diseases.
A Yale University-led team of researchers have created a vaccine that protects against malaria infection in mouse models, paving the way for the development of a human vaccine that works by targeting the specific protein that parasites use to evade the immune system. The study was published by Nature Communications.
Languishing with fever and frustrated by delays in diagnosing his illness, Brian Gitta came up with a bright idea: A malaria test that would not need blood samples or specialized laboratory technicians.